SB130
To Remove The Reimbursement Cap On Pediatric Bone Marrow Transplant Services Within The Arkansas Medicaid Program.
Last Action (May 1, 2023): Sine Die adjournment
Sponsors
AI-Generated Summary
Senate Bill 130 proposes to amend the Arkansas Medicaid Program to prohibit the imposition of reimbursement caps for pediatric bone marrow transplant services. The bill mandates that the Arkansas Medicaid Program must remove existing caps and refrain from establishing new ones for these specific medical procedures. Additionally, the legislation directs the Arkansas Department of Human Services to seek any necessary federal waivers or state plan amendments required to implement these changes. The primary goal is to ensure that coverage for pediatric bone marrow transplants is not restricted by predetermined financial limits within the state's Medicaid program.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries are pediatric patients covered under the Arkansas Medicaid program who require bone marrow transplants. Their families also benefit by potentially reducing or eliminating the financial burden associated with transplant costs that exceed previous reimbursement limits. Furthermore, healthcare providers and hospitals that specialize in pediatric oncology and transplant services will benefit from increased coverage for these high-cost procedures.
Who Might Suffer?
The primary entity negatively impacted is the Arkansas state government, specifically the Department of Human Services, which will face increased financial obligations and budgetary pressures due to the removal of reimbursement caps. Arkansas taxpayers may also be indirectly impacted, as the state must allocate additional funds to support the increased Medicaid expenditures required to cover these unlimited transplant costs.
Get Notified
Receive an email when this bill's status changes.